Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(40.0%)
N/A
2(40.0%)
Phase 1
1(20.0%)
5Total
Phase 3(2)
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05312463Phase 1Unknown

Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome

Role: collaborator

NCT04340297Phase 3Unknown

Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease

Role: collaborator

NCT02803736Not ApplicableUnknown

Effectiveness of Acupuncture for Breast Cancer Related Lymphedema

Role: collaborator

NCT02726477Not ApplicableUnknown

Efficacy and Safety of Wuling San on Breast Cancer-related Lymphedema

Role: collaborator

NCT01479504Phase 3Unknown

A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Role: collaborator

All 5 trials loaded